TNF and cardiomyopathy: The Wnt/β-catenin/RAS axis is also implicated in DOXO-induced cardiomyopathy, with TNF-α acting as an upstream stimulator.Inhibition of TNF-α using infliximab or rolipram has shown protective effects against DOXO-induced cardiomyopathy in animal models.